共 53 条
[1]
Newburger J.W.(2004)Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association Circulation 110 2747-71
[2]
Takahashi M.(2012)Epidemiology and management of Kawasaki disease Drugs 72 1029-38
[3]
Gerber M.A.(2011)Etanercept as adjunctive treatment for acute Kawasaki disease: study design and rationale Am Heart J 161 494-9
[4]
Luca N.J.C.(2002)Does abciximab enhance regression of coronary aneurysms resulting from Kawasaki disease? Pediatrics 109 E4-8
[5]
Yeung R.S.M.(2010)Does abciximab promote coronary artery remodeling in patients with Kawasaki disease? Am J Cardiol 105 1625-9
[6]
Portman M.A.(2006)Salicylate for the treatment of Kawasaki disease in children Cochrane Database Syst Rev 18 CD004175-7
[7]
Olson A.(2003)Intravenous immunoglobulin for the treatment of Kawasaki disease in children Cochrane Database Syst Rev 4 CD004000-8
[8]
Soriano B.(1991)A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome N Engl J Med 324 1633-7
[9]
Williams R.V.(1986)The treatment of Kawasaki syndrome with intravenous gamma globulin N Engl J Med 315 341-9
[10]
Wilke V.M.(1984)High-dose intravenous gammaglobulin for Kawasaki disease Lancet 2 1055-6